Australian Developed Healthcare Products Launching in the Indian Market

Fortis Malar Hospital

Australia is developing a new range of healthcare products, that are innovative and thoughtful for the streaming market of India.

India has a huge population pool and an emerging healthcare sector to cater to that. Also, the number of diseases like cardio-vascular diseases, diabetes and tuberculosis are on a rise. Australia is designing products for this specific market, after studying the potential and the need of the country. The George Institute for Global Health and Sydney-based University of New South Wales, have partnered to develop the products, namely, An artificial heart pump to help patients of end-stage heart failure, an automated device that helps a bed-ridden patient turn sides and prevent bed sores, a strip that calculates your insulin status and helps detect diabetes, and a highly sensitive device that can detect TB bacteria within minutes.

These products also will be cost effective and fill the need of millions of patients. These Australian health start-ups have products that can affect many lives. Hospitals in India are also set to welcome these new providers.  An artificial heart developed by Circulatory Support Technologies could help thousands of patients in need of a heart transplant. “Each year, there are 1.5 million new patients of heart failure in India. Of them, 20 per cent suffer from terminal heart failure. The artificial heart pump that is currently available in the market costs about 70 lakhs, unaffordable for a majority of the population. A device such as this, that could cost about Rs 5 lakh, will really help these patients,” said Dr K.R. Balakrishnan, director, cardiac sciences, Fortis Malar Hospital, Chennai.

The developers are presently in India visiting to set their products for clinical trials and get all necessary approvals to breakthrough the Indian healthcare framework. Other products like diabetes point-of-care test and a point-of-care plug and play microscope that can accurately and specifically measure tuberculosis bacteria, in a few minutes may also see application in Indian hospitals and healthcare centers soon.

Harinder Sidhu, Australian High Commissioner to India said in a statement, that the health industry was a key part of the ten sectors identified as part of Australia’s ‘An India Economic Strategy, 2035’. “I see enormous potential for collaboration and co-operation between the two countries in this sector. India needs low-cost solutions, and Australia, with its sophisticated bio-medical and technology eco-system could offer these solutions with an emphasis on quality. These Australian companies represent ground-breaking innovations in the health sector. This forms a part of the Australian government’s efforts to build connections and create opportunities for start-up sectors in the two countries,” Sidhu said.